Search results with tag "Prescribing information these highlights do not include all"
These highlights do not include all the information needed ...
www.pharma.us.novartis.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIGAMOX® solution safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
documents.impaxlabs.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975 -----INDICATIONS AND USAGE-----
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARANESP-safely and effectively. See full prescribing information for ARANESP. -ARANESP® (darbepoetin alfa) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2001 WARNING: ESAs INCREASE THE RISK OF DEATH,
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.alnylam.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ONPATTRO® safely and effectively. See full prescribing information for ONPATTRO. ONPATTRO (patisiran) lipid complex injection, for intravenous use Initial U.S. Approval: 2018 -----RECENT MAJOR CHANGES-----
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) tablets, for oral use Initial U.S. Approval: 2006-----INDICATIONS AND USAGE members -----
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
labeling.bayerhealthcare.comHIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use MIRENA safely and effectively. See full prescribing information for MIRENA. MIRENA (levonorgestrel-releasing intrauterine system) Initial U.S. Approval: 2000 -----RECENT MAJOR CHANGES-----
HIGHLIGHTS OF PRESCRIBING INFORMATION • These …
labeling.bayerhealthcare.comHIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use SKYLA safely and effectively. See full prescribing information for SKYLA. SKYLA (levonorgestrel-releasing intrauterine system) Initial U.S. Approval: 2000 •---- …
HIGHLIGHTS OF PRESCRIBING INFORMATION • These …
labeling.bayerhealthcare.comHIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use KYLEENA safely and effectively. See full prescribing information for KYLEENA. KYLEENA (levonorgestrel-releasing intrauterine system) Initial U.S. Approval: 2000 ----- RECENT MAJOR CHANGES -----
HIGHLIGHTS OF PRESCRIBING INFORMATION Before …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. • JARDIANCE ® (empagliflozin) tablets, for oral use . Initial U.S. Approval: 2014 . …
HIGHLIGHTS OF PRESCRIBING INFORMATION thereafter or …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 -----RECENT MAJOR CHANGES-----